Barry P. Avner

547 total citations
19 papers, 384 citations indexed

About

Barry P. Avner is a scholar working on Physiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Barry P. Avner has authored 19 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Barry P. Avner's work include Asthma and respiratory diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Respiratory and Cough-Related Research (3 papers). Barry P. Avner is often cited by papers focused on Asthma and respiratory diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Respiratory and Cough-Related Research (3 papers). Barry P. Avner collaborates with scholars based in United States and Switzerland. Barry P. Avner's co-authors include John W. Jenne, Karen Corbett, John A. Trotter, B.J. Noland, Edson X. Albuquerque, Steven M. Yabek, Masashi Sasa, Thomas W. Chick, Chun Shi Lin and Leon Hurwitz and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Barry P. Avner

19 papers receiving 355 citations

Peers

Barry P. Avner

MB

PHYSI

PRM

CMN

ONCOL

Beverly Noe United States

G. C. Budd United States

Y.H. Lau United States

Robert Bridenbaugh United States

Delia Beju United States

Frederick J. Darfler United States

Michela Bernardini France

Marie-Odile Lonchampt France

Eduardo Fernández-Segura Spain

Eiko Ueno Japan

Beverly Noe United States

Barry P. Avner

208 ×1.1

MB

32 ×0.3

PHYSI

34 ×0.5

PRM

122 ×1.9

CMN

31 ×0.6

ONCOL

Citations per year, relative to Barry P. Avner Barry P. Avner (= 1×) peers Beverly Noe

Countries citing papers authored by Barry P. Avner

Since Specialization

Citations

This map shows the geographic impact of Barry P. Avner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry P. Avner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry P. Avner more than expected).

Fields of papers citing papers by Barry P. Avner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry P. Avner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry P. Avner. The network helps show where Barry P. Avner may publish in the future.

Co-authorship network of co-authors of Barry P. Avner

This figure shows the co-authorship network connecting the top 25 collaborators of Barry P. Avner. A scholar is included among the top collaborators of Barry P. Avner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry P. Avner. Barry P. Avner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Avner, Barry P., Andrew Hanly, Carolyn Mies, et al.. (1997). Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors. Cytometry. 28(1). 81–89. 51 indexed citations

2.

Avner, Barry P., Andrew Hanly, Carolyn Mies, et al.. (1997). Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors. Cytometry. 28(1). 81–89. 6 indexed citations

3.

Koechli, Ossi R., Barry P. Avner, Bernd‐Uwe Sevin, et al.. (1993). Application of the adenosine triphosphate‐cell viability assay in human breast cancer chemosensitivity testing: A report on the first results. Journal of Surgical Oncology. 54(2). 119–125. 20 indexed citations

4.

Avner, Barry P., et al.. (1991). Evaluation and clinical relevance of patient immune responses to intravenous therapy with murine monoclonal antibodies conjugated to adriamycin.. PubMed. 3(1). 14–21. 5 indexed citations

5.

Avner, Barry P., et al.. (1989). Therapeutic murine monoclonal antibodies developed for individual cancer patients.. PubMed. 8(1). 25–36. 4 indexed citations

6.

Orr, Douglas, R. K. Oldham, M. G. Lewis, et al.. (1989). Phase I trial of mitomycin C immunoconjugates cocktails in human malignancies.. PubMed. 1(4). 229–40. 5 indexed citations

7.

Avner, Barry P., et al.. (1989). Immunoconjugates of doxorubicin and murine antihuman breast carcinoma monoclonal antibodies prepared via an N-hydroxysuccinimide active ester intermediate of cis-aconityl-doxorubicin: preparation and in vitro cytotoxicity.. PubMed. 1(3). 170–4. 16 indexed citations

8.

Oldham, R. K., M. G. Lewis, Douglas Orr, et al.. (1988). Adriamycin custom-tailored immunoconjugates in the treatment of human malignancies.. PubMed. 1(2). 103–13. 14 indexed citations

9.

Avner, Barry P. & John W. Jenne. (1981). Desensitization of isolated human bronchial smooth muscle to β-receptor agonists. Journal of Allergy and Clinical Immunology. 68(1). 51–57. 25 indexed citations

10.

Trotter, John A., Karen Corbett, & Barry P. Avner. (1981). Structure and function of the murine muscle–tendon junction. The Anatomical Record. 201(2). 293–302. 61 indexed citations

11.

Avner, Barry P., et al.. (1981). A method for culturing canine tracheal smooth muscle cells in vitro: Morphologic and pharmacologic observations. The Anatomical Record. 200(3). 357–370. 18 indexed citations

12.

Chick, Thomas W., et al.. (1980). Tachyphylaxis to inhaled isoproterenol and the effect of methylprednisolone in dogs. Journal of Allergy and Clinical Immunology. 65(2). 105–109. 34 indexed citations

13.

Yabek, Steven M. & Barry P. Avner. (1980). Effects of prostacyclin (PGI2) and indomethacin on neonatal lamb mesenteric and renal artery responses to electrical stimulation and norepinephrine. Prostaglandins. 19(1). 23–30. 16 indexed citations

14.

Yabek, Steven M. & Barry P. Avner. (1979). Effects of prostaglandin E1 and indomethacin on fetal and neonatal lamb mesenteric artery responses to norepinephrine. Prostaglandins. 17(2). 227–233. 6 indexed citations

15.

Avner, Barry P. & B.J. Noland. (1978). In vivo desensitization to beta receptor mediated bronchodilator drugs in the rat: decreased beta receptor affinity.. Journal of Pharmacology and Experimental Therapeutics. 207(1). 23–33. 33 indexed citations

16.

Lin, Chun Shi, Leon Hurwitz, John W. Jenne, & Barry P. Avner. (1977). Mechanism of isoproterenol-induced desensitization of tracheal smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 203(1). 12–22. 30 indexed citations

17.

Avner, Barry P. & D. J. Triggle. (1974). 1,4-Benzodioxanes as reversible and irreversible antagonists at adrenergic receptors. Journal of Medicinal Chemistry. 17(2). 197–200. 3 indexed citations

18.

Sasa, Masashi, Barry P. Avner, & Edson X. Albuquerque. (1973). Actions of β-blocking agents on membrane excitability of the lobster giant axon. European Journal of Pharmacology. 23(1). 97–103. 20 indexed citations

19.

Albuquerque, Edson X., Masashi Sasa, Barry P. Avner, & John W. Daly. (1971). Possible Site of Action of Batrachotoxin. Nature New Biology. 234(46). 93–95. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact